Skip to main content
. 2020 Feb 12;12:7. doi: 10.1186/s11689-020-9309-6

Table 1.

Demographic and clinical variables in the study sample as compared to the Phelan-McDermid Syndrome International Registry (PMSIR) participants 13 or older

This study (n = 38) PMSIR (n = 130) Comparison
Mean age at data collection 24.7 years ± 9.92 20.8 years ± 7.65

t(166) = 2.56, p = .011

χ2(1) = 10.21, p = .001

Gender
 Male 18% (7/38) 47% (61/130) χ2(1) = 10.20, p = .001
 Female 82% (31/38) 53% (69/130)
Genetic defect a
 Terminal deletion 61% (23/38) 91% (118/130) χ2(1) = 19.79, p < .001
 Interstitial deletion 2% (3/130)
SHANK3 sequence variant 39% (15/38) 7% (9/130)
ASD diagnosis (ever)d 55% (21/38) 41% (37/91b) χ2(1) = 2.105, p = .147
History afebrile seizure(s) 39% (15/38) 41% (37/91) χ2(1) = .044, p = .834
Walked independently (ever) 100% (38/38) 81% (64/79c) χ2(1) = 8.212, p = .004
Spoke in phrases or sentences (ever) 79% (30/38) 51% (40/79) χ2(1) = 8.317, p = .004
Toileted independently “always” or “sometimes” (ever) 89% (34/38) 48% (38/79) χ2(1) = 18.029, p < .001
Dressed self independently (ever) 78% (30/38) 42% (33/79) χ2(1) = 13.26, p < .001
Chronic constipation 84% (32/38) 15% (14/91) χ2(1) = 55.428, p = <.001
Acute urinary retention 47% (18/38) 3% (3/87) χ2(1) = 37.091, p < .001

aAmong all Registry participants (n = 509, excluding the study participants), there are 467 terminal deletions (92%), 10 interstitial deletions (2%) and 32 sequence variants (6%)

b91 participants in this age range (excluding the study participants) completed the Registry Clinical Questionnaire

c79 participants in this age range (excluding the study participants) completed the Registry Developmental Questionnaire

dPrior to the onset of neuropsychiatric illness, 42% (16/38) of participants had ASD diagnoses